Salvatore Lopez - Concepedia

Author

Salvatore Lopez

Also Known As

Ana Maria Tirado Errazquin, S Lopez, S Lpez, S López, S Orona López, S. Lopez, S. López, Salvatore LOPEZ, Salvatore Lopez, Sam G Lopez

198

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Yale University Università Campus Bio-Medico Fondazione IRCCS Istituto Nazionale dei Tumori Magna Graecia University Sapienza University of Rome

About

Salvatore Lopez is an author at Yale University specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	1.2K
2	Cell Biology	11	11	436
3	Engineering	3	3	128
4	Public Health	3	3	82
5	Biostatistics	1	1	14

Salvatore Lopez

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition Siming Zhao, Stefania Bellone, Salvatore Lopez, Proceedings of the National Academy of Sciences	2016	227
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study Giorgio Bogani, Violante Di Donato, Francesco Sopracordevole, Gynecologic Oncology Laser Conization5-Year Follow-up StudyRecurrence RateOphthalmologyOculoplastics	2020	107
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors Charles H. Li, Elena Bonazzoli, Stefania Bellone, Proceedings of the National Academy of Sciences	2018	94
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy Luca Zammataro, Salvatore Lopez, Stefania Bellone, Proceedings of the National Academy of Sciences	2019	92
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression Jonathan Black, Gulden Menderes, Stefania Bellone, Molecular Cancer Therapeutics	2016	91
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro Stefania Bellone, Eliana Bignotti, Silvia Lonardi, Gynecologic Oncology Tumor BiologyUterine TumorsTumoral PathologyPolymerase εMedicine	2016	81
Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients Stefania Bellone, Floriana Centritto, Jonathan Black, Gynecologic Oncology Cancer ImmunosurveillancePolymerase εMedicineTumor ImmunityUltra-mutated Tumors	2015	80
T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2 Roberta Nicoletti, Salvatore Lopez, Stefania Bellone, Clinical & Experimental Metastasis Ovarian CarcinosarcomasNovel Antibody-drug ConjugateMedicineGynecologyImmune Checkpoint Inhibitor	2014	65
Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine Giorgio Bogani, Valentina Chiappa, Salvatore Lopez, Healthcare EngineeringDigital PathologyGynecologyPathologyGynecology Oncology	2022	62
Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan Burak Zeybek, Aránzazu Manzano, Anna Bianchi, Scientific Reports	2020	58

Page 1